News All News

TFome technology, advanced through Blavatnik Biomedical Accelerator, may contribute to new cell therapies

Harvard stem cell research, currently in mice, receives support from Sarepta to advance in-vivo genome editing toward prospective therapy

Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease

Injectable sponge-like gel enhances the quantity and quality of T-cells